Showing 81-100 of 723 for: Cochrane Systematic Reviews > Musculoskeletal 
- Balneotherapy (or spa therapy) for rheumatoid arthritis
Cochrane Systematic Reviews, 11-Apr-2015
No cure for rheumatoid arthritis (RA) is known at present, so treatment often focuses on management of symptoms such as pain, stiffness and mobility. Treatment options include pharmacological interventions, physical therapy treatments and balneotherapy. B
- Balneotherapy for osteoarthritis
Cochrane Systematic Reviews, 10-Jun-2008
Balneotherapy (or spa therapy, mineral baths) for patients with arthritis is one of the oldest forms of therapy. One of the aims of balneotherapy is to soothe the pain and as a consequence to relieve patients' suffering and make them feel well. In this up
- Beclomethasone for asthma in children: effects on linear growth
Cochrane Systematic Reviews, 26-Jul-1999
Inhaled steroids play a central role in the management of childhood asthma. There is concern about their side effects, especially on growth. However asthma may also cause growth retardation. Growth rates are not stable, so randomised controlled parallel g
- Bed rest during pregnancy for preventing miscarriage
Cochrane Systematic Reviews, 20-Apr-2005
Miscarriage is pregnancy loss before 23 weeks of gestational age. It happens in 10% to 15% of pregnancies depending on maternal age and parity. It is associated with chromosomal defects in about a half or two-thirds of cases. Many interventions have been
- Bed rest for acute uncomplicated myocardial infarction
Cochrane Systematic Reviews, 18-Apr-2007
Bed rest is prescribed to all patients with acute myocardial infarction (AMI), but to a variable extent. Current guidelines (American College of Cardiology/ American Heart Association) recommend at least 12 hours bed rest in patients with uncomplicated ST
- Bed rest in hospital for suspected impaired fetal growth
Cochrane Systematic Reviews, 22-Apr-1996
Bed rest in hospital or at home is widely advised for many complications of pregnancy. The increased clinical supervision needs to be balanced with the risk of thrombosis, the stress on the pregnant women, as well as the costs to families and health servi
- Bed rest in singleton pregnancies for preventing preterm birth
Cochrane Systematic Reviews, 30-Mar-2015
Bed rest in hospital or at home is widely recommended for the prevention of preterm birth. This advice is based on the observation that hard work and hard physical activity during pregnancy could be associated with preterm birth and with the idea that bed
- Bed rest with or without hospitalisation for hypertension during pregnancy
Cochrane Systematic Reviews, 19-Oct-2005
Bed rest or restriction of activity, with or without hospitalisation, have been advocated for women with hypertension during pregnancy to improve pregnancy outcome. However, benefits need to be demonstrated before such interventions can be recommended sin
- Behavioural treatment for chronic low‐back pain
Cochrane Systematic Reviews, 7-Jul-2010
Behavioural treatment is commonly used in the management of chronic low-back pain (CLBP) to reduce disability through modification of maladaptive pain behaviours and cognitive processes. Three behavioural approaches are generally distinguished: operant, c
- Biologics for rheumatoid arthritis: an overview of Cochrane reviews
Cochrane Systematic Reviews, 15-Jan-2013
The biologic disease-modifying anti-rheumatic drugs (DMARDs) are very effective in treating rheumatoid arthritis (RA), however there is a lack of head-to-head comparison studies.
- Biopsychosocial rehabilitation for upper limb repetitive strain injuries in working age adults
Cochrane Systematic Reviews, 4-Nov-2008
Upper limb repetitive strain injury is a common problem in western countries, causing human suffering and huge economical losses. Patients with prolonged pain associated with repetitive tasks in the work place can face both psychological and physical diff
- Bioresorbable fixation devices for musculoskeletal injuries in adults
Cochrane Systematic Reviews, 4-Nov-2008
Bioresorbable implants for musculoskeletal injuries involving bone and ligaments in adults might have significant advantages compared to the conventionally used non-resorbable metal implants because they lead to a gradual transfer of the mechanical load f
- Bisphosphonate therapy for children and adolescents with secondary osteoporosis
Cochrane Systematic Reviews, 24-May-2010
Children with chronic illnesses are at increased risk for reductions in bone strength and subsequent fractures (osteoporosis), either due to the impact of the underlying condition on skeletal development or due to the osteotoxic effect of medications (e.g
- Bisphosphonates and other bone agents for breast cancer
Cochrane Systematic Reviews, 30-Oct-2017
Bone is the most common site of metastatic disease associated with breast cancer (BC). Bisphosphonates inhibit osteoclast-mediated bone resorption, and novel targeted therapies such as denosumab inhibit other key bone metabolism pathways. We have studied
- Bisphosphonates for advanced prostate cancer
Cochrane Systematic Reviews, 26-Dec-2017
The prevalence and incidence of pain and skeletal complications of metastatic bone disease such as pathologic fractures, spinal cord compression and hypercalcemia is high and an important contributor to morbidity, poor performance status and decreased qua
- Bisphosphonates for osteoporosis in people with cystic fibrosis
Cochrane Systematic Reviews, 13-Mar-2014
Osteoporosis is a bone mineralisation disorder occurring in about one third of adults with cystic fibrosis. Bisphosphonates can increase bone mineral density and decrease the risk of new fractures in post-menopausal women and people receiving long-term or
- Bisphosphonates for steroid‐induced osteoporosis
Cochrane Systematic Reviews, 5-Oct-2016
This is an update of a Cochrane Review first published in 1999. Corticosteroids are widely used in inflammatory conditions as an immunosuppressive agent. Bone loss is a serious side effect of this therapy. Several studies have examined the use of bisphosp
- Bisphosphonates for the relief of pain secondary to bone metastases
Cochrane Systematic Reviews, 22-Apr-2002
Bisphosphonates form part of standard therapy for hypercalcemia and the prevention of skeletal events in some cancers. However, the role of bisphosphonates in pain relief for bony metastases remains uncertain.
- Bisphosphonates in multiple myeloma: an updated network meta‐analysis
Cochrane Systematic Reviews, 18-Dec-2017
Bisphosphonates are specific inhibitors of osteoclastic activity and are used in the treatment of patients with multiple myeloma (MM). While bisphosphonates are shown to be effective in reducing vertebral fractures and pain, their role in improving overal
- Bone morphogenetic protein (BMP) for fracture healing in adults
Cochrane Systematic Reviews, 11-May-2010
Delay in fracture healing is a complex clinical and economic issue for patients and health services.
